Hello Par Holders
Not sure what thread to post on correct me if im wrong from my understanding the FDA approves animal drugs.
Cartrophen (Pentosan polysulfate) is approved from the the FDA to treat pain and inflammation in our beloved pet friends and is labelled as a DMOAD.
I understand our validation is more scrutinised however we know it works for us humans and our trials are validating this,so if (Pentosan Polysulfate IPPS) is classed as a DMOAD for animals due to the benefits it creates and the effects are the same for us as it is for our fury friends then surely we have a better than great chance of having it approved as a DMOAD.
research reports and media, page-2992
-
- There are more pages in this discussion • 1,196 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.035(12.7%) |
Mkt cap ! $108.4M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 31.0¢ | 27.5¢ | $108.9K | 371.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 17420 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |